Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors

Gene Therapy

Volumn 9, Issue 22, 2002, Pages 1542-1560

  Reddy, J A ^a   Abburi, C ^a   Hofland, H ^b   Howard, S J ^a   Vlahov, I ^a   Wils, P ^b   Leamon, C P ^a  

^a Endocyte Inc   (United States)

^b AVANIR PHARMACEUTICALS   (United States)

Author keywords

Cationic liposome; Folate receptor; Gene therapy; Lipoplex; Tumor Targeting

Indexed keywords

CATION; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; FOLIC ACID; LIPID; LIPOSOME; LUCIFERASE; MACROGOL; PHOSPHATIDYLETHANOLAMINE; PLASMID DNA; PROTAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BINDING AFFINITY; CATION TRANSPORT; CONTROLLED STUDY; DNA TRANSFECTION; DRUG BINDING; DRUG BLOOD LEVEL; DRUG TARGETING; FEMALE; GENE TRANSFER; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PERITONEUM TUMOR; PRIORITY JOURNAL; REVIEW; TUMOR MODEL;

ANIMALS; CARRIER PROTEINS; CELL LINE; FEMALE; FOLIC ACID; GENE TARGETING; GENE THERAPY; LIPOSOMES; LUCIFERASES; MICE; MICE, INBRED DBA; PERITONEAL NEOPLASMS; PROTEIN BINDING; RECEPTORS, CELL SURFACE; TRANSFECTION;

ANIMALIA;

EID: 0036859261     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301833     Document Type: Review

References (46)

1. Dass CR, Burton MA. Lipoplexes and tumours. A review. J Pharm Pharmacol 1999; 51: 755-770.
2. Brigham KL et al. In vivo transfection of murine lungs with a functioning prokaryotic gene using a liposome vehicle. Am J Med Sci 1989; 298: 278-281.
3. Felgner PL et al. Improved cationic lipid formulations for in vivo gene therapy. Ann NY Acad Sci 1995; 772: 126-139.
4. Templeton NS, Lasic DD. New directions in liposome gene delivery. Mol Biotechnol 1999; 11: 175-180.
5. Caplen NJ et al. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat Med 1995; 1: 39-46.
6. Stephan DJ et al. A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo. Hum Gene Ther 1996; 7: 1803-1812.
7. Wheeler CJ et al. A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. Proc Natl Acad Sci USA 1996; 93: 11454-11459.
8. Alton EW et al. Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat Genet 1993; 5: 135-142.
9. Parker SE et al. Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo. Cancer Gene Ther 1996; 3: 175-185.
10. Stopeck AT et al. Phase I study of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7, in patients with metastatic melanoma. J Clin Oncol 1997; 15: 341-349.
11. Rubin J et al. Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7. Gene Therapy 1997; 4: 419-425.
12. Lee RJ, Huang L. Folate-targeted, anionic liposome-entrapped polylysine-condensed DNA for tumor cell-specific gene transfer. J Biol Chem 1996; 271: 8481-8487.
13. Reddy JA, Low PS. Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation. J Control Release 2000; 64; 27-37.
14. Reddy JA, Dean D, Kennedy MD, Low PS. Optimization of folate-conjugated liposomal vectors for folate receptor-mediated gene therapy. J Pharm Sci 1999; 88: 1112-1118.
15. Xu L et al. Systemic p53 gene therapy in combination with radiation results in human tumor regression. Tumor Targeting 1999; 4: 92-104.
16. Xu L et al. Transferrin-liposome-mediated systemic p53 gene therapy in combination with radiation results in regression of human head and neck cancer xenografts. Hum Gene Ther 1999; 10: 2941-2952.
17. Hwang SH, Hayashi K, Takayama K, Maitani Y. Liver-targeted gene transfer into a human hepatoblastoma cell line and in vivo by sterylglucoside-containing cationic liposomes. Gene Therapy 2001; 8: 1276-1280.
18. Leamon CP, Low PS. Folate-mediated targeting: from diagnostics to drug and gene delivery. Drug Discov Today 2001; 6: 44-51.
19. Reddy JA, Low PS. Folate-mediated targeting of therapeutic and imaging agents to cancers. Crit Rev Ther Drug Carrier Syst 1998; 15: 587-627.
20. Leamon CP, Pastan I, Low PS. Cytotoxicity of folate-Pseudomonas exotoxin conjugates toward tumor cells. Contribution of translocation domain. J Biol Chem 1993; 268: 24847-24854.
21. Lee RJ, Low PS. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J Biol Chem 1994; 269: 3198-3204.
22. Ciuchi F et al. Self-recognition and self-assembly of folic acid salts: columnar liquid crystalline polymorphism and the column growth process. J Am Chem Soc 1994; 116: 7064.
23. Antony AC, Utley C, Van Horne KC, Kolhouse JF. Isolation and characterization of a folate receptor from human placenta. J Biol Chem 1981; 256: 9684-9692.
24. Jeppesen C et al. Impact of polymer tether length on multiple ligand-receptor bond formation. Science 2001; 293: 465-468.
25. Torchilin VP. Molecular mechanism of liposome and immunoliposome steric protection with poly(ethylene glycol): theoretical and experimental proofs of polymer chain flexibility. In: Lasic DDaMF (ed.). Stealth Liposomes. CRC Press: Boca Raton, 1995, pp 51-62.
26. Byk G, Scherman D, Schwartz B, Dubertret C. Lipopolyamines as transfection agents and pharmaceutical uses thereof: U.S. patent, 2001.
27. Pitard B. Sterically stabilized BGTC-based lipoplexes: structural features and gene transfection into the mouse airways in vivo. J Gene Med 2001 (in Press).
28. Zhu N, Liggitt D, Liu Y, Debs R. Systemic gene expression after intravenous DNA delivery into adult mice. Science 1993; 261: 209-211.
29. Liu Y et al. Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery. Nat Biotechnol 1997; 15: 167-173.
30. Ishida O, Maruyama K, Sasaki K, Iwatsuru M. Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice. Int J Pharm 1999; 190: 49-56.
31. Straubinger RM, Hong K, Friend DS, Papahadjopoulos D. Endocytosis of liposomes and intracellular fate of encapsulated molecules: encounter with a low pH compartment after internalization in coated vesicles. Cell 1983; 32: 1069-1079.
32. Watts C, Marsh M. Endocytosis: what goes in and how? J Cell Sci 1992; 103: 1-8.
33. Mounkes LC et al. Proteoglycans mediate cationic liposome-DNA complex-based gene delivery in vitro and in vivo. J Biol Chem 1998; 273: 26164-26170.
34. Zelphati O, Uyechi LS, Barron LG, Szoka Jr. FC. Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells. Biochim Biophys Acta 1998; 1390: 119-133.
35. Gao X, Huang L. Cationic liposome-mediated gene transfer. Gene Therapy 1995; 2: 710-722.
36. Fasbender A et al. Effect of co-lipids in enhancing cationic lipid-mediated gene transfer in vitro and in vivo. Gene Therapy 1997; 4: 716-725.
37. Leamon CP, DePrince RB, Hendren RW. Folate-mediated drug delivery: effect of alternative conjugation chemistry. J Drug Target 1999; 7: 157-169.
38. Aoki K et al. Gene therapy for peritoneal dissemination of pancreatic cancer by liposome-mediated transfer of herpes simplex virus thymidine kinase gene. Hum Gene Ther 1997; 8: 1105-1113.
39. Kikuchi A et al. Development of novel cationic liposomes for efficient gene transfer into peritoneal disseminated tumor. Hum Gene Ther 1999; 10: 947-955.
40. Kiyasu Y, Kaneshima S, Koga S. Morphogenesis of peritoneal metastasis in human gastric cancer. Cancer Res 1981; 41: 1236-1239.
41. Niedbala MJ, Crickard K, Bernacki RJ. Interactions of human ovarian tumor cells with human mesothelial cells grown on extracellular matrix. An in vitro model system for studying tumor cell adhesion and invasion. Exp Cell Res 1985; 160: 499-513.
42. Takeshita S et al. Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation. In vitro and in vivo findings in a rabbit model of vascular injury. J Clin Invest 1994; 93: 652-661.
43. Chan SY et al. Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. Cell 2001; 106: 117-126.
44. Deen WM, Bridges CR, Brenner BM. Biophysical basis of glomerular permselectivity. J Membr Biol 1983; 71: 1-10.
45. Li S, Huang L. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Therapy 1997; 4: 891-900.
46. Mathias CJ et al. Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate. J Nucl Med 1996; 37: 1003-1008.